Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Melanogenesis enzymes are a group of specialized catalytic proteins, primarily Tyrosinase (TYR), Tyrosinase-related protein 1 (TYRP1), and Tyrosinase-related protein 2 (also known as Dopachrome tautomerase or DCT), that orchestrate the production of melanin within melanocytes (UniProt P14679, P17642). Tyrosinase serves as the rate-limiting enzyme of the pathway, initiating the process by hydroxylating L-tyrosine to L-DOPA and subsequently oxidizing it to dopaquinone (PubMed 30835092). These enzymes are critical for determining skin, hair, and eye color and provide a vital defense mechanism against ultraviolet (UV) radiation-induced DNA damage. Dysregulation or overactivity of these enzymes leads to various pigmentary disorders, such as melasma, solar lentigines, and post-inflammatory hyperpigmentation (PubMed 25611360). Consequently, they are the primary therapeutic targets for dermatological skin-lightening agents like hydroquinone, kojic acid, and thiamidol, which act by inhibiting their catalytic activity (PubChem CID 785). In oncology, these enzymes are also significant as markers and potential targets in melanoma, where their expression is often markedly upregulated.
Competitive or non-competitive inhibition of tyrosinase catalytic activity, modulation of enzyme expression, and acceleration of enzyme degradation.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melanogenesis enzymes (TYR/TYRPs).